You are here

angioedema

Shire Rises on Encouraging Angioedema Results

TheStreet.com

Thu, 02/23/17 - 09:25 pm

BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27

Yahoo/Globe Newswire

Sun, 05/25/14 - 10:22 am

This Company Is Focused on Delivering Value to Patients and Shareholders

Motley Fool

Sun, 10/6/13 - 09:19 am

BioCryst: The Next Orphan Drug $1B+ Company

Seeking Alpha

Sat, 08/3/13 - 10:27 am

ViroPharma up, FDA lifts ban

Yahoo/Investor's Business Daily

Sat, 09/22/12 - 02:22 pm

Shire Enters a Crowded Market

Motley Fool

Thu, 09/1/11 - 11:37 am

ViroPharma Inks Deal with Halozyme

Yahoo/Zacks

Sat, 05/14/11 - 12:31 pm

hereditary angiodema

ViroPharma Drug Nears EU Approval

Investor's Business Daily

Sat, 04/2/11 - 10:19 am

FDA rejects filing on Santarus angioedema drug

Yahoo/AP

Mon, 02/28/11 - 12:17 pm

Dyax's response for more information on DX-88 gets FDA acceptance, decision expected by Dec.

Yahoo/AP

Mon, 06/8/09 - 10:04 am

ViroPharma says FDA wants new study of Cinryze as treatment for acute angioedema attacks

Yahoo/AP

Thu, 06/4/09 - 09:37 am